ACADIA Pharmaceuticals Inc. (ACAD) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$21.51
Day's range
$22.62

Acadia Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 02/17/2026 42.90 M $1.15 B   0.00% 25.41%
BLACKROCK, INC. 02/12/2026 20.76 M $554.38 M   2.40% 12.29%
VANGUARD GROUP INC 01/29/2026 15.15 M $404.76 M   -0.17% 8.98%
STATE STREET CORP 02/13/2026 7.91 M $211.30 M   9.03% 4.69%
RTW INVESTMENTS, LP 02/17/2026 7.14 M $190.83 M   0.00% 4.23%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 3.38 M $90.21 M   127.22% 2.00%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 3.24 M $86.54 M   3.41% 1.92%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 2.92 M $78.02 M   4.39% 1.73%
PALO ALTO INVESTORS LP 02/17/2026 2.48 M $66.35 M   0.70% 1.47%
FIRST TRUST ADVISORS LP 02/13/2026 2.27 M $60.63 M   16.82% 1.34%
BRAIDWELL LP 02/17/2026 2.03 M $54.28 M   -14.57% 1.20%
GOLDMAN SACHS GROUP INC 03/25/2026 1.57 M $41.94 M   -25.32% 0.93%
FRED ALGER MANAGEMENT, LLC 02/17/2026 1.56 M $41.67 M   -0.45% 0.92%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 1.55 M $41.49 M   5.75% 0.92%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 1.53 M $40.94 M   5.73% 0.91%
NORGES BANK 02/10/2026 1.51 M $40.27 M   100.00% 0.89%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 1.50 M $40.13 M   -8.87% 0.89%
02/17/2026 1.42 M $37.91 M   100.00% 0.84%
CITADEL ADVISORS LLC 02/17/2026 1.37 M $36.52 M   322.68% 0.81%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/13/2026 1.30 M $34.65 M   111.33% 0.77%
NORTHERN TRUST CORP 02/17/2026 1.24 M $33.01 M   -5.19% 0.73%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.22 M $32.62 M   37.57% 0.72%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 1.20 M $32.12 M   101.63% 0.71%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.17 M $31.31 M   -2.64% 0.69%
MORGAN STANLEY 02/13/2026 1.14 M $30.50 M   -3.91% 0.68%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.12 M $29.89 M   68.06% 0.66%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 03/17/2026 1.11 M $29.73 M   7.40% 0.66%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 01/22/2026 1.07 M $28.65 M   -3.44% 0.64%
NUVEEN, LLC 02/12/2026 1.06 M $28.25 M   10.85% 0.63%
D. E. SHAW & CO., INC. 02/17/2026 1.03 M $27.43 M   -34.23% 0.61%
LOGOS GLOBAL MANAGEMENT LP 02/17/2026 850.00 K $22.70 M   100.00% 0.50%
INVESCO LTD. 02/19/2026 847.96 K $22.65 M   14.50% 0.50%
DEUTSCHE BANK AG\ 02/11/2026 828.59 K $22.13 M   -45.57% 0.49%
EMERALD ADVISERS, LLC 02/09/2026 811.20 K $21.67 M   42.40% 0.48%
UBS GROUP AG 01/29/2026 769.39 K $20.55 M   15.72% 0.46%
BANK OF NEW YORK MELLON CORP 02/10/2026 751.99 K $20.09 M   -5.51% 0.45%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 745.36 K $19.91 M   7.00% 0.44%
FMR LLC 02/17/2026 726.96 K $19.42 M   9.18% 0.43%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 681.10 K $18.19 M   3.69% 0.40%
FISHER ASSET MANAGEMENT, LLC 02/09/2026 665.09 K $17.76 M   4.17% 0.39%
AMERIPRISE FINANCIAL INC 02/17/2026 662.24 K $17.68 M   -3.31% 0.39%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/15/2026 658.81 K $17.32 M   25.39% 0.39%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 641.51 K $17.13 M   -6.41% 0.38%
JUPITER ASSET MANAGEMENT LTD 02/10/2026 621.05 K $16.59 M   30.39% 0.37%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 615.17 K $16.43 M   -44.12% 0.36%
ALGERT GLOBAL LLC 02/17/2026 614.41 K $16.41 M   53.56% 0.36%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 604.75 K $16.15 M   -2.59% 0.36%
RICE HALL JAMES & ASSOCIATES, LLC 02/17/2026 603.74 K $16.13 M   -1.82% 0.36%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 580.97 K $15.52 M   -13.08% 0.34%
MILLENNIUM MANAGEMENT LLC 02/17/2026 553.67 K $14.79 M   -62.67% 0.33%

Acadia Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 498 institutional investors and hedge funds held shares of Acadia Pharmaceuticals Inc. The most heavily invested institutionals were:

DIMENSIONAL FUND ADVISORS LP: 3.16 M

Pictet Asset Management Holding SA: 2.03 M

Nuveen, LLC: 1.04 M

Allspring Global Investments Holdings, LLC: 954,855

VANGUARD FIDUCIARY TRUST CO: 875,720

DEUTSCHE BANK AG\: 840,414

98.53% of Acadia Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 203.29 M shares in the last 24 months. This purchase volume represents approximately $4.59 B in transactions.